TIANJIN DEV (00882) announced that on December 24, 2025, its indirectly non-wholly owned subsidiary, Lisheng Pharmaceutical, entered into the 12th wealth management agreement with Industrial Bank Co., Ltd. to subscribe for a structured deposit with a principal amount of RMB85 million (approximately HKD93.41 million).